Canaccord Genuity Reiterates a 'Buy' on Triangle Petroleum (TPLM); Bakken Accelerating; Possible Two Well Catalyst
Get Alerts TPLM Hot Sheet
Price: $0.01 --0%
Rating Summary:
3 Buy, 9 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Rating Summary:
3 Buy, 9 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Join SI Premium – FREE
Canaccord Genuity reiterates a 'Buy' on Triangle Petroleum (NYSE: TPLM) price target of $11.00 (from $9.00).
Analyst, John Gerdes, said, "Triangle recently commenced Bakken operations with encouraging results. The latest well averaged ~1,250 Boepd over the initial seven days and should recover 600+ Mboe for ~$10 million. This month, the pressure pumping subsidiary is commencing operations. We view this unit as a creative solution to ensure availability of reasonably priced stimulation services for the E&P business while generating a strong return on capital."
Upcoming catalysts: recently completes two well tests which could extend production and increase company-wide outlook.
For an analyst ratings summary and ratings history on Triangle Petroleum click here. For more ratings news on Triangle Petroleum click here.
Shares of Triangle Petroleum closed at $5.95 yesterday.
Analyst, John Gerdes, said, "Triangle recently commenced Bakken operations with encouraging results. The latest well averaged ~1,250 Boepd over the initial seven days and should recover 600+ Mboe for ~$10 million. This month, the pressure pumping subsidiary is commencing operations. We view this unit as a creative solution to ensure availability of reasonably priced stimulation services for the E&P business while generating a strong return on capital."
Upcoming catalysts: recently completes two well tests which could extend production and increase company-wide outlook.
For an analyst ratings summary and ratings history on Triangle Petroleum click here. For more ratings news on Triangle Petroleum click here.
Shares of Triangle Petroleum closed at $5.95 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- META to capture largest share of users, SNAP to benefit from ad budget shifts - Canaccord Genuity weighs in on TikTok ban
- Keurig Dr Pepper (KDP) PT Raised to $39 at Jefferies
- Intra-Cellular Therapies (ITCI) PT Raised to $107 at Canaccord Genuity
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Bakken Formation, Canaccord GenuitySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!